Form 4: InspireMD Director Paul Stuka Buys 10,130 Shares

InspireMD Director Paul Stuka acquired 10,130 shares of common stock at $1.85 per share, signaling confidence in the company.

Summary

• Paul Stuka, a Director of InspireMD, Inc. (NSPR), purchased 10,130 shares of common stock.
• The transaction occurred on December 4, 2025, at a price of $1.85 per share.
• Following this transaction, Paul Stuka directly beneficially owns 383,845 shares of common stock.
• Additionally, Paul Stuka indirectly beneficially owns 444,195 shares of common stock through Osiris Investment Partners, L.P., where he serves as the managing member of the general partner, Osiris Partners, LLC.
• The reporting person disclaims beneficial ownership of the indirectly held securities except to the extent of his pecuniary interest therein, and no transaction was effected by him with respect to these specific securities.

Sentiment

Score: 7

Explanation: The sentiment is positive due to a director's direct purchase of company stock, which typically signals confidence in the company's future.

Positives

• A Director's purchase of company stock indicates confidence in the company's future prospects and valuation.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This insider transaction reflects an individual director's belief in InspireMD's value, but the filing itself does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator, potentially increasing confidence in the stock.
• Employees might perceive this as a sign of stability and positive future outlook from leadership.

Key Dates

Recommendation

A director's purchase of company stock is a positive signal, suggesting confidence in the company's prospects. While this alone might not warrant a 'buy' recommendation without further fundamental analysis, it supports a 'hold' position for existing investors and indicates a potentially favorable outlook for those considering investment.

Keywords

InspireMD, NSPR, Paul Stuka, Director, Insider Purchase, Stock Acquisition, Common Stock, Beneficial Ownership, Form 4